Phase II trial of adjuvant de-escalated radiation plus adjuvant nivolumab for intermediate-high risk P16+oropharynx cancer.Heath Devin Skinner,Dan Paul Zandberg, Adam Raben,Shaum Sridharan,Mark Kubik,Jose Zevallos,Seungwon Kim,Umamaheswar Duvvuri,James Ohr,William E. Gooding,Robert L. FerrisJOURNAL OF CLINICAL ONCOLOGY(2023)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要